GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Gujarat Kidney and Super Speciality Ltd

Gujarat Kidney & Super Speciality Q2 FY27 Unaudited Standalone/Consolidated Results Approved

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 04 Nov 2026, 07:02 PM IST  ·  BSE ID: 4eab0b18-f1b3-4cba-92d9-5865358bbabf
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board has approved its latest financial results for the quarter ending September 30, 2026.
🤖 AI Summary
  • Gujarat Kidney and Super Speciality Ltd Board approved unaudited standalone and consolidated financial results for Q2 FY27.
  • The Board meeting, held on November 04, 2026, considered recommendations from the Audit Committee.
  • Statutory Auditors, M/s. Y M Shah & Co., Vadodara, issued unmodified limited review reports on results.
  • Integrated financial filing in XBRL format is being done separately as per SEBI circulars.
  • Meeting commenced at 4:45 p.m. and concluded at 6:00 p.m. on November 04, 2026.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this specific filing.
👤
Who Is Affected
All shareholders are affected as this filing confirms the completion of the review and approval process for the Q2 FY27 financial results.
🔍
Management Signal
This indicates management's adherence to regulatory timelines for financial reporting and transparency by confirming unmodified auditor reports.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Review the upcoming XBRL filing for detailed Q2 FY27 standalone and consolidated financial results.
Monitor future filings for Q3 FY27 results for revenue and profit trends.
Track any further updates regarding financial performance or operational changes.
LOW RISK This filing is procedural, confirming approval of results and unmodified audit reports; it presents no new financial risks.
💡 Investor Takeaway
Gujarat Kidney and Super Speciality Ltd's Board approved Q2 FY27 standalone and consolidated unaudited financial results on November 04, 2026, with unmodified limited review reports. The specific financial performance numbers for the quarter are not included in this filing.
📅 Company Track Record
Gujarat Kidney and Super Speciality Ltd reported FY26 Profit After Tax at Rs. 990.14 Lacs in its May 2026 filing. A March 2026 filing noted delayed Q2 results (for a prior period) with profit up 69.5% YoY to Rs. 389.98 lacs, but short-term debt surged 1,229% to Rs. 1,270.71 lacs.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What financial period do these approved results cover for Gujarat Kidney and Super Speciality Ltd?
These approved results cover the quarter ended September 30, 2026, which corresponds to Q2 FY27 for Gujarat Kidney and Super Speciality Ltd.
Were the auditor reports for Gujarat Kidney and Super Speciality Ltd's Q2 FY27 results modified?
No, the auditor reports on both standalone and consolidated financial results for Q2 FY27 are declared as unmodified by the company.
When did the Board meeting take place for Gujarat Kidney and Super Speciality Ltd?
The Board meeting to consider and approve the financial results was held on November 04, 2026, commencing at 4:45 p.m. and concluding at 6:00 p.m.
Where can the detailed financial results for Gujarat Kidney and Super Speciality Ltd's Q2 FY27 be found?
The detailed unaudited standalone and consolidated financial results for Q2 FY27 will be filed separately in XBRL format as an integrated filing.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.